Your browser doesn't support javascript.
loading
Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
van den Besselaar, Antonius M H P; Stavelin, Anne; Kitchen, Steve; Bryant, Michelle; Tripodi, Armando; Scalambrino, Erica; Clerici, Marigrazia; Herbel, Petra; Jünschke, Anja; Meyer Dos Santos, Sascha; Meijer, Piet; Niessen, René W L M; Meijers, Joost C M; Thelwell, Craig; Cuker, Adam; Kung, Chun; Cao, Zhenghua; Zander, Norbert; Iwasaki, Yosuke; Depasse, François; van Rijn, Claudia; Baktawar, Shanti; Abdoel, Charmane; Cobbaert, Christa M.
Affiliation
  • van den Besselaar AMHP; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.m.h.p.van_den_besselaar@lumc.nl.
  • Stavelin A; The Norwegian Organisation for Quality Improvement of Laboratory Examinations, Bergen, Norway.
  • Kitchen S; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.
  • Bryant M; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.
  • Tripodi A; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.
  • Scalambrino E; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.
  • Clerici M; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano and Fondazione Luigi Villa, Milano, Italy.
  • Herbel P; Roche Diagnostics GmbH, Mannheim, Germany.
  • Jünschke A; Roche Diagnostics GmbH, Mannheim, Germany.
  • Meyer Dos Santos S; Roche Diagnostics GmbH, Mannheim, Germany.
  • Meijer P; External quality Control of diagnostic Assays and Tests (ECAT) Foundation, Voorschoten, the Netherlands.
  • Niessen RWLM; Federation of Dutch Thrombosis Services, Leiden, the Netherlands.
  • Meijers JCM; Department of Molecular Hematology, Sanquin Research, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Thelwell C; Therapeutic Reference Materials, Medicines and Healthcare Products Regulatory Agency, National Institute for Biological Standards and Control, Potters Bar, UK.
  • Cuker A; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kung C; Werfen, Orangeburg, New York, USA.
  • Cao Z; Werfen, Orangeburg, New York, USA.
  • Zander N; Siemens Healthineers, Marburg, Germany.
  • Iwasaki Y; Sysmex Corporation, Kobe, Japan.
  • Depasse F; Diagnostica Stago, Asnières-sur-Seine, France.
  • van Rijn C; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Baktawar S; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Abdoel C; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Cobbaert CM; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
J Thromb Haemost ; 22(4): 1236-1248, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38128762
ABSTRACT
Calibration of prothrombin time (PT) in terms of international normalized ratio (INR) has been outlined in "Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy" (World Health Organization, 2013). The international standard ISO 175112020 presents requirements for manufacturers of in vitro diagnostic (IVD) medical devices (MDs) for documenting the calibration hierarchy for a measured quantity in human samples using a specified IVD MD. The objective of this article is to define an unequivocal, metrologically traceable calibration hierarchy for the INR measured in plasma as well as in whole blood samples. Calibration of PT and INR for IVD MDs according to World Health Organization guidelines is similar to that in cases where there is a reference measurement procedure that defines the measurand for value assignment as described in ISO 175112020. We conclude that, for PT/INR standardization, the optimal calibration hierarchy includes a primary process to prepare an international reference reagent and measurement procedure that defines the measurand by a value assignment protocol conforming to clause 5.3 of ISO 175112020. A panel of freshly prepared human plasma samples from healthy adult individuals and patients on vitamin K antagonists is used as a commutable secondary calibrator as described in ISO 175112020. A sustainable metrologically traceable calibration hierarchy for INR should be based on an international protocol for value assignment with a single primary reference thromboplastin and the harmonized manual tilt tube technique for clotting time determination. The primary international reference thromboplastin reagent should be used only for calibration of successive batches of the secondary reference thromboplastin reagent.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboplastin / Chemistry, Clinical Limits: Adult / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboplastin / Chemistry, Clinical Limits: Adult / Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2024 Document type: Article